Acute pancreatitis: nutritional management protocols during autolytic pancreatic tissue damage

Acute pancreatitis is a severe inflammatory condition of the pancreas that, depending on its form, can extend to surrounding tissues and organs. The two most common etiologies are gallstone obstruction and excessive alcohol consumption, which trigger duct blockage or direct injury to acinar cells. The pancreas combines endocrine functions (such as producing insulin to regulate blood glucose) with exocrine duties (synthesizing and secreting digestive enzymes into the duodenum).

During an acute attack, a destructive autolytic process occurs: enzymes that normally remain inactive until reaching the intestinal lumen become prematurely activated, digesting the structural proteins of the pancreas itself. The primary symptom is an intense, sudden epigastric pain radiating to the back, frequently accompanied by nausea, vomiting, and abdominal distension. Diagnosis is confirmed through biochemical markers—specifically a threefold or greater elevation in serum and urinary amylase or lipase—alongside imaging modalities like abdominal ultrasound or computed tomography. Regardless of severity, immediate hospitalization is strictly mandatory.

During the initial phase of severe symptoms, oral nutrition is completely withheld to rest the pancreas and prevent exocrine stimulation. Gastric aspiration is occasionally employed, and maintaining optimal fluid balance is paramount. Intravenous fluid resuscitation is the standard approach to support systemic perfusion and adequate urinary output.

Because acute pancreatitis triggers an intense catabolic state marked by rapid lean mass depletion, nutrient delivery is critical. Historically, total parenteral nutrition providing 1900–2400 kcal daily (distributed among glucose, lipid emulsions, and amino acids) was favored. However, extensive clinical research now demonstrates superior clinical outcomes with early enteral nutrition delivered via a jejunal tube. This method preserves gut mucosal integrity, curtails systemic infectious complications, and reduces metabolic instability such as hyperglycemia. Specialized peptide-based elemental formulas or those enriched with medium-chain triglycerides (MCT) are utilized due to their high digestibility and minimal pancreatic stimulation.

In mild cases of acute pancreatitis, oral nutrition can typically be resumed around day four, provided clinical criteria such as pain relief, normalized amylase and lipase levels, and active bowel sounds are met. For the first two to three days, the diet consists of liquid or semisolid meals restricted to 200–300 ml per serving. Crucially, foods must be exceptionally bland, and dietary fat is severely restricted.

Progression back to a regular diet is gradual, requiring 3 to 4 months for mild cases and up to 6 months following severe attacks. A typical expansion protocol begins in the first month with approximately 40 g of fat and 65 g of protein daily, progressing slightly in the second month. Once all clinical symptoms resolve and tolerance is established, a full, easily digestible diet is implemented with frequent, small meals (3–4 times daily). Frying, deep-frying, and roasting are prohibited; boiling, steaming, or stewing are preferred. High-fiber products (whole-grain bread, coarse groats, legumes) are excluded initially, and fruits and vegetables must be peeled, cooked, and served as purees or mousses. Complete abstinence from alcohol is an absolute, lifelong medical requirement.